IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. It utilizes a platform that integrates access to a dynamic IMID patient biobank, curated clinical data, proprietary multiomics molecular data, and clinical expertise. IMIDomics analytics platform extracts insights into disease biology and patient conditions through a proprietary interactive portal.